companydata.dkcompanydata.dk

Vitexia ApS: Financial statements 2022

CVR: 41374675

Source: annual report 2022, Danish Business Authority

01/01/202231/12/2022

Vitexia ApS (CVR 41374675) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -61,943 and a net result of DKK 50,997 compared with DKK -4,085 the year before. Equity in the 2022 report amounted to DKK 82,704. The solvency ratio was 1.5%.

Gross Profit
DKK -61,943
Profit/Loss
DKK 50,997
Equity
DKK 82,704
Total Assets
DKK 5,584,237
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022--62 t.51 t.83 t.0
2021--5 t.-4 t.32 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Vitexia ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Vitexia ApS: The 2021 annual report is outJun 29, 2022

Vitexia ApS has published its annual report for 2021. Gross profit came to DKK -5,000, and the net result was DKK -4,085.

Zentexia Group ApS registered as owner of Vitexia ApSApr 4, 2022

As of April 4, 2022, Zentexia Group ApS is registered as an owner of Vitexia ApS with an ownership share of 90%.

Chromexa ApS changes name to Vitexia ApSMar 31, 2022

On March 31, 2022, the company changed its name from Chromexa ApS to Vitexia ApS.

About Vitexia ApS

Vitexia ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2020. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Chromexa ApS. The management consists of Morten Weidner. The company is owned by Zentexia Group ApS. In 2025, the company reported a gross profit of DKK -21,726 and a net result of DKK 1,517,822 compared with DKK -133,806 the year before. Equity in the 2025 report amounted to DKK 1,339,864.

Source: annual report 2025, Danish Business Authority

Other financial years